Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus

Clinical trial NCT00765817 · COMPLETED

Trial details

NCT number: NCT00765817
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2008-10-01
Primary completion: 2010-01-01
Enrollment: 261

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.